Accordingly, a significant negative correlation between USP22 expression and several UPR-responsive genes including ATF3, PPP1R15A, DDIT3, and BCL2L1 was observed in HER2+-BC patients (Fig. S2E). This evidence concerns the gene USP22 and breast cancer.